Efficacy and Safety of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide Fumarate in Treating Acute-on-Chronic Liver Failure with Hepatitis B Virus: A Network Meta-analysis. [PDF]
Liu J, Bi Y, Ma X, Xin Y.
europepmc +1 more source
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates. [PDF]
Pons-Faudoa FP +20 more
europepmc +1 more source
Comparison of efficacy and safety of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate treatment in patients with high viral load of hepatitis B virus. [PDF]
Zhang C +6 more
europepmc +1 more source
Tenofovir alafenamide fumarate therapy in subjects with positive HBV-DNA and normal levels of alanine transaminase: a study protocol for a randomised controlled trial. [PDF]
Wang L +7 more
europepmc +1 more source
Switch to Fixed Dose of Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate Versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate in Virologically Suppressed Adults on Efavirenz-Based Regimens: 48-Week Results of a Real-world, Prospective, Observational Cohort Study. [PDF]
Li A +12 more
europepmc +1 more source
Weight gain on tenofovir alafenamide fumarate-based therapy compared to tenofovir disoproxil fumarate- and abacavir-based therapy in children and young people living with HIV in Europe. [PDF]
European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group.
europepmc +1 more source
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate Regimen and Its Effect on Liver Steatosis Assessed by Fibroscan. [PDF]
Trizzino M +5 more
europepmc +1 more source
Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort. [PDF]
Rotea-Salvo S +12 more
europepmc +1 more source
Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B. [PDF]
Cao F +18 more
europepmc +1 more source

